Tag: Drug development

Addressing Issues in Contract Manufacturing Onboarding for Process Performance Reproduction In the realm of pharmaceutical production, engaging contract manufacturing organizations (CMOs) poses unique challenges, particularly when process performance is not…

Addressing Inconsistent Process Performance During Scale-Up in Pharmaceuticals In the landscape of pharmaceutical manufacturing, ensuring consistent process performance during scale-up is critical to product quality and regulatory compliance. When a…

Understanding Equipment Discrepancies During Site Transfers: A Practical Guide for Validation and Compliance Equipment discrepancies during site transfers can significantly impact drug manufacturing processes, leading to quality issues, compliance failures,…

Addressing Site Capability Mismatch in Contract Manufacturing Onboarding: A Governance Model In the context of pharmaceutical contract manufacturing onboarding, site capability mismatches can disrupt formulation and process development, posing risks…

Preventing Issues with Incomplete Tech Transfer Packages During Contract Manufacturing Onboarding In today’s dynamic pharmaceutical landscape, the adequacy of tech transfer packages significantly impacts the success of contract manufacturing onboarding…

Addressing Overlooked Equipment Differences in Site Transfers – A Comprehensive CAPA Playbook In the complex world of pharmaceutical manufacturing, the nuances of equipment differences during site transfers can lead to…

How to Address Equipment Discrepancies During PPQ Planning to Avoid Tech Transfer Challenges Pharmaceutical professionals often encounter unexpected challenges during the Process Performance Qualification (PPQ) phase, primarily due to overlooked…

Effective Strategies for Managing Scale-Up Batch Failures in Pharmaceutical Manufacturing In the intricate world of pharmaceutical manufacturing, the transition from formulation and process development to commercial scale can sometimes lead…

Addressing Inconsistencies in Process Performance Ahead of Inspections: A Practical Playbook In pharmaceutical manufacturing, instances where process performance is not reproduced during the crucial phase of inspection preparation can pose…

Tackling Knowledge Transfer Gaps During Commercial Scale-Up with a Risk-Based Approach As pharmaceutical companies transition from small-scale development to commercial manufacturing, they often encounter knowledge transfer gaps that can jeopardize…

Addressing Incomplete Tech Transfer Packages During Inspection Prep The pharmaceutical landscape continuously evolves, presenting numerous challenges during the tech transfer phase, especially when preparing for regulatory inspections. An incomplete tech…